GRAIL Management
Management criteria checks 2/4
GRAIL's CEO is Bob Ragusa, appointed in Oct 2021, has a tenure of 3.08 years. total yearly compensation is $9.88M, comprised of 7.9% salary and 92.1% bonuses, including company stock and options. directly owns 0.39% of the company’s shares, worth €1.51M. The average tenure of the management team and the board of directors is 4.2 years and 5.9 years respectively.
Key information
Bob Ragusa
Chief executive officer
US$9.9m
Total compensation
| CEO salary percentage | 7.9% |
| CEO tenure | 3.1yrs |
| CEO ownership | 0.4% |
| Management average tenure | 4.2yrs |
| Board average tenure | 5.9yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -US$3b |
| Mar 31 2024 | n/a | n/a | -US$1b |
| Dec 31 2023 | US$10m | US$780k | -US$1b |
| Jan 01 2023 | n/a | n/a | -US$5b |
Compensation vs Market: Bob's total compensation ($USD9.88M) is above average for companies of similar size in the German market ($USD1.18M).
Compensation vs Earnings: Bob's compensation has increased whilst the company is unprofitable.
CEO
Bob Ragusa (64 yo)
3.1yrs
Tenure
US$9,878,221
Compensation
Mr. Robert P. Ragusa, also known as Bob, serves as Director at Dante Labs Inc. He serves as the Chief Executive Officer at GRAIL, Inc. since October 14, 2021 and is its Director. He is Independent Director...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 3.1yrs | US$9.88m | 0.39% € 1.5m | |
| President | no data | US$4.34m | 0.23% € 904.7k | |
| Chief Financial Officer | no data | US$3.60m | 0.048% € 188.0k | |
| Senior VP of Global Development & Operations | no data | no data | no data | |
| Senior VP of Research & Chief Scientific Officer | no data | no data | no data | |
| General Counsel | no data | no data | no data | |
| Chief People Officer | no data | no data | no data | |
| VP and Head of Government Affairs & Alliance Development | 5.3yrs | no data | no data | |
| President Biopharma Business & Europe | 4.6yrs | no data | no data | |
| Senior VP of Software Engineering & Chief Security Officer | 4.8yrs | no data | no data | |
| VP of Product & Head of Program Management Organization | 3.8yrs | no data | no data | |
| Senior VP of Research & Development | 3.8yrs | no data | no data |
4.2yrs
Average Tenure
Experienced Management: NL0's management team is considered experienced (4.2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | no data | US$9.88m | 0.39% € 1.5m | |
| Director | 8.8yrs | no data | no data | |
| Chairman of the Board | less than a year | no data | 0.0053% € 20.7k | |
| Director | 6.3yrs | no data | no data | |
| Director | no data | no data | 0.0032% € 12.2k | |
| Director | 8.8yrs | no data | no data | |
| Director | 7.6yrs | no data | no data | |
| Director | 4.5yrs | no data | no data | |
| Director | 5.5yrs | no data | no data | |
| Director | less than a year | no data | 0.0034% € 13.2k | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data |
5.9yrs
Average Tenure
64yo
Average Age
Experienced Board: NL0's board of directors are considered experienced (5.9 years average tenure).